The Effect of Licorice Root Extract on the Treatment of Patients with Covid-19
Phase 3
- Conditions
- People with COVID 19 whose disease has been confirmed by Real Time PCR.U07.1
- Registration Number
- IRCT20201111049348N1
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Includes people with laboratory confirmation of Quid 19 virus regardless of clinical signs and close association
Age over 15 years
Exclusion Criteria
Patient request to leave the study for any reason
Request the treating physician to exclude the patient from the study for any reason
History of drug allergies
History of allergies
Patients with immunodeficiency
Patients with hypertension
Group of patients with underlying disease
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Interleukin 6( IL-6). Timepoint: Major measurements of variables are performed on the first day before the intervention and on the 10th day after the intervention. Method of measurement: Using the kit.;Interleukin One Beta( IL-1ß). Timepoint: Major measurements of variables are performed on the first day before the intervention and on the 10th day after the intervention. Method of measurement: Using the kit.;Alpha tumor necrosis factor(TNF-a). Timepoint: Major measurements of variables are performed on the first day before the intervention and on the 10th day after the intervention. Method of measurement: Using the kit.
- Secondary Outcome Measures
Name Time Method